AU5437300A - Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment - Google Patents
Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatmentInfo
- Publication number
- AU5437300A AU5437300A AU54373/00A AU5437300A AU5437300A AU 5437300 A AU5437300 A AU 5437300A AU 54373/00 A AU54373/00 A AU 54373/00A AU 5437300 A AU5437300 A AU 5437300A AU 5437300 A AU5437300 A AU 5437300A
- Authority
- AU
- Australia
- Prior art keywords
- antibodies
- treatment
- diagnostic kit
- nucleus pulposus
- disc herniation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902155 | 1999-06-09 | ||
SE9902155A SE9902155L (en) | 1999-06-09 | 1999-06-09 | Serum antibodies |
PCT/SE2000/001179 WO2000075659A1 (en) | 1999-06-09 | 2000-06-07 | Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5437300A true AU5437300A (en) | 2000-12-28 |
Family
ID=20415987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54373/00A Abandoned AU5437300A (en) | 1999-06-09 | 2000-06-07 | Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5437300A (en) |
SE (1) | SE9902155L (en) |
WO (1) | WO2000075659A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1244388T3 (en) | 1999-12-06 | 2007-05-14 | Warsaw Orthopedic Inc | Device for treating intervertebral discs |
US20040054414A1 (en) | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
CN100394989C (en) | 2002-11-15 | 2008-06-18 | 华沙整形外科股份有限公司 | Collagen-based materials and methods for augmenting intervertebral discs |
US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
US8118779B2 (en) | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
CN109475611A (en) * | 2016-04-04 | 2019-03-15 | Gu投资公司 | For treating the method and composition of the protrusion of the intervertebral disc |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4628027A (en) * | 1982-05-19 | 1986-12-09 | Molecular Engineering Associates, Ltd. | Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
US5399347A (en) * | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
DE3918082A1 (en) * | 1989-06-02 | 1991-01-24 | Max Planck Gesellschaft | AGENT FOR AUTOIMMUNE DISEASES |
HUT61487A (en) * | 1989-12-20 | 1993-01-28 | Brigham & Womens Hospital | Process for producing aerosol pharmaceutical composition comprising autoantigens |
WO1994014070A1 (en) * | 1992-12-04 | 1994-06-23 | Shriners Hospitals For Crippled Children | Immunoassay for the measurement of collagen cleavage in cartilage |
US5856446A (en) * | 1995-07-07 | 1999-01-05 | Autoimmune Inc. | Method of treating rheumatoid arthritis with low dose type II collagen |
AUPO571297A0 (en) * | 1997-03-19 | 1997-04-10 | Montech Medical Developments Pty Ltd | Method for the diagnosis of rheumatoid arthritis |
-
1999
- 1999-06-09 SE SE9902155A patent/SE9902155L/en not_active Application Discontinuation
-
2000
- 2000-06-07 AU AU54373/00A patent/AU5437300A/en not_active Abandoned
- 2000-06-07 WO PCT/SE2000/001179 patent/WO2000075659A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
SE9902155D0 (en) | 1999-06-09 |
SE9902155L (en) | 2000-12-10 |
WO2000075659A1 (en) | 2000-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPP676898A0 (en) | Sampling first in blood collection | |
AU6712500A (en) | Improvements in or relating to sterilising preparations | |
AU5788300A (en) | Medical treatment method and kit | |
HUP9901874A3 (en) | Human antibodies binding human tnfalfa, pharmaceutical compositions containing thereof and use thereof | |
AU3501197A (en) | Human stem cell antigens, dna coding therefor and their use | |
AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
AU7676300A (en) | Human anti-adipocyte monoclonal antibodies and their use | |
AU5252698A (en) | Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1 | |
AU4378996A (en) | Cell compositions for use in transplantation and ex vivo gene therapy | |
AU2001226651A1 (en) | Porphyrin containing lactic acid bacterial cells and use thereof | |
AU5437300A (en) | Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment | |
AU1705599A (en) | Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood | |
AU2530199A (en) | Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods | |
AU3844299A (en) | Improvements in medical guidewires | |
AU2087799A (en) | Diagnostic and therapeutic methods based upon valpha24jalphaq t cells | |
AU1206701A (en) | Antibiotic-metal complexes in the detection of gram-negative bacteria and other biological analytes | |
AU2002220744A1 (en) | T-cell epitope of the papillomavirus L1 and E7 protein and use thereof in diagnostics and therapy | |
HUP0202444A3 (en) | Method and kit for immuno-detecting bacteria in blood and tissues | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
AU1310697A (en) | Magnetic substance for local hyperthermal treatment of tumours, in particular smaller tumours | |
AU6835300A (en) | Diagnostic kit and use thereof | |
AU5134600A (en) | Full-length molecules expressed in human tissues | |
AU4468897A (en) | Topical preparation for introducing peptidaceous pharmacons in living organisms | |
AU2192497A (en) | Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof | |
AU6088300A (en) | Modulation of egr-1 and egr-2 in heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |